LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

Search

Design Therapeutics Inc

Gesloten

3.81 -1.04

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

3.74

Max

3.93

Belangrijke statistieken

By Trading Economics

Inkomsten

-4.1M

-18M

EPS

-0.31

Werknemers

56

EBITDA

-3.7M

-20M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+89.41% upside

Dividenden

By Dow Jones

Volgende Winsten

4 aug 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-64M

200M

Vorige openingsprijs

4.85

Vorige sluitingsprijs

3.81

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

Design Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

23 mei 2025, 20:33 UTC

Acquisities, Fusies, Overnames

Salesforce in Talks to Buy Informatica, Bloomberg Reports, Citing Sources

23 mei 2025, 21:57 UTC

Populaire aandelen

Stocks to Watch: Apple, Booz Allen, Constellation Energy, Intuit -- WSJ

23 mei 2025, 21:15 UTC

Top Nieuws

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 4th Update

23 mei 2025, 21:04 UTC

Acquisities, Fusies, Overnames

Real-Estate Broker Douglas Elliman Could See Takeover Battle After Report of Bid -- Barrons.com

23 mei 2025, 20:56 UTC

Top Nieuws
Acquisities, Fusies, Overnames

Salesforce Back in Deal Talks With Informatica -- WSJ

23 mei 2025, 20:51 UTC

Top Nieuws

Boeing in Tentative Agreement to Pay $1.1 Billion to Avoid Trial for 737 MAX Crashes -- WSJ

23 mei 2025, 20:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

23 mei 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

23 mei 2025, 20:41 UTC

Top Nieuws

Stocks Fall on Tariff Broadside, After Week of Bond Market Agita -- WSJ

23 mei 2025, 20:28 UTC

Top Nieuws

Trump Threatens EU With 50% Tariffs, Takes Aim at Apple; Nasdaq Drops -- WSJ

23 mei 2025, 20:06 UTC

Top Nieuws

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 5th Update

23 mei 2025, 20:06 UTC

Acquisities, Fusies, Overnames

Salesforce Stock Drops, Informatica Soars. A Deal May Be Back on the Table. -- Barrons.com

23 mei 2025, 19:50 UTC

Top Nieuws

Trump's Tariffs: Where Things Stand -- 16th Update

23 mei 2025, 19:28 UTC

Acquisities, Fusies, Overnames

Trump on Truth Social: 'Bulk of That Investment Will Occur in the Next 14 Months'

23 mei 2025, 19:28 UTC

Acquisities, Fusies, Overnames

Trump on Truth Social: 'This Will Be a Planned Partnership Between United States Steel and Nippon Steel'

23 mei 2025, 19:27 UTC

Acquisities, Fusies, Overnames

Trump on Truth Social: 'Proud to Announce That, After Much Consideration and Negotiation, US Steel Will REMAIN in America'

23 mei 2025, 19:20 UTC

Marktinformatie

Crude Futures Post Modest Weekly Losses -- Market Talk

23 mei 2025, 19:18 UTC

Marktinformatie

U.S. Natural Gas Futures End Week Unchanged -- Market Talk

23 mei 2025, 18:57 UTC

Top Nieuws

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 4th Update

23 mei 2025, 18:54 UTC

Top Nieuws

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- Update

23 mei 2025, 18:53 UTC

Top Nieuws
Acquisities, Fusies, Overnames

McDonald's Bids Goodbye to CosMc's, Its Space Alien-Themed Spinoff -- WSJ

23 mei 2025, 18:52 UTC

Acquisities, Fusies, Overnames

DDC Enterprise Issues 254,333 Class A Ordinary Shrs in Exchange for 21 BTC, Valued at About $2.28M in Current Market Price

23 mei 2025, 18:13 UTC

Marktinformatie

Market Talk Roundup: Latest on U.S. Politics

23 mei 2025, 18:13 UTC

Marktinformatie

Gold Trades Higher on Reminder of Risk -- Market Talk

23 mei 2025, 18:00 UTC

Top Nieuws

Apple's Stock Still Not Pricing in Trump's Demands - Heard on the Street -- WSJ

23 mei 2025, 17:51 UTC

Marktinformatie
Winsten

Workday Sees Higher Bar for Guidance -- Market Talk

23 mei 2025, 17:42 UTC

Top Nieuws

Dow Drops, Trump Threatens EU With 50% Tariffs, Takes Aim at Apple -- WSJ

23 mei 2025, 17:39 UTC

Marktinformatie

U.S. Oil Rig Count Falls to Lowest Level Since November 2021 -- Market Talk

23 mei 2025, 17:07 UTC

Top Nieuws

Trump's Tariffs: Where Things Stand -- 15th Update

23 mei 2025, 17:04 UTC

Marktinformatie
Winsten

Workday Appears to Have Upside Potential on Conservative Outlook -- Market Talk

Peer Vergelijking

Prijswijziging

Design Therapeutics Inc Prognose

Koersdoel

By TipRanks

89.41% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 7.33 USD  89.41%

Hoogste 12 USD

Laagste 5 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Design Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

3 ratings

1

Buy

2

Hold

0

Sell

Technische score

By Trading Central

3.26 / 3.63Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Bearish Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Design Therapeutics Inc

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.